mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.0085 |
0.8 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
-0.0095 |
0.8 |
mRNA |
WH-4-023 |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
SGC0946 |
GDSC1000 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
pandacostat |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0088 |
0.8 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
JNK-9L |
GDSC1000 |
pan-cancer |
AAC |
-0.0082 |
0.8 |